Screening

14 million Americans will have Alzheimer’s disease by 2060, and many cases of cognitive impairment go undetected by PCPs. Key points from a recent summit offer new insights into screening methods.

The U.S. Preventive Services Task Force highlights key research gaps in their recommendations intended to promote public health for all.

The approach offers bilingual support, mailed outreach, and no-cost screening.

DermaSensor is a new FDA-approved handheld that is designed to scan and assess skin lesions in the primary care clinical setting. Rebecca Hartman, MD, MPH, describes how it works.

New research from the American Association of Nurse Practitioners affirms the current problems of the U.S. health care system, as well as some improvements from 2023.

How physicians can help close the awareness gap and support families to screen for type 1 diabetes